<DOC>
	<DOCNO>NCT02688114</DOCNO>
	<brief_summary>Radiofrequency ablation ( RFA ) mainstay treatment patient Barrett 's esophagus ( BE ) dysplasia . For unclear reason , Barrett 's esophagus recur successful RFA treatment approximately 1/3 patient . The aim study characterize heal process esophageal mucosa , histologically molecular level , RFA non-dysplastic Barrett 's esophagus .</brief_summary>
	<brief_title>Healing Esophageal Mucosa After RFA Barrett 's Esophagus</brief_title>
	<detailed_description>Radiofrequency ablation ( RFA ) mainstay treatment patient Barrett 's esophagus ( BE ) dysplasia . For unclear reason , Barrett 's esophagus recur successful RFA treatment approximately 1/3 patient . Little known esophagus heals RFA treatment , good understand heal process might provide insight prevent Barrett 's metaplasia recur successful ablation . The aim study characterize heal process esophageal mucosa , histologically molecular level , RFA non-dysplastic Barrett 's esophagus . Patients Barrett 's esophagus undergo surveillance endoscopy biopsy . This follow RFA treatment BE follow endoscopy perform 1 , 2 , 4 week RFA . Healing time point assess endoscopically , molecular marker related heal study . Stem cell expression marker , immune cell marker epithelial-mesenchymal transition compare baseline expression patient .</detailed_description>
	<mesh_term>Barrett Esophagus</mesh_term>
	<criteria>U.S . Veteran Barrett 's esophagus inability provide inform consent esophageal varix treatment warfarin coagulopathy precludes safe biopsy esophagus ( include platelet count &lt; 100,000/mm3 , INR ( international normalize ratio ) &gt; 1.5 ) allergy fluorescein sodium comorbidity preclude safe participation study pregnancy breastfeed status</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>